JOHN GILL
CIK 1409939 · President and CEO · last filed 2026-05-01
JOHN GILL is a President and CEO who has filed 28 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for ALT, was dated May 1, 2026. Across all open-market trades the lifetime net is −$54.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $56.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$56.6K
2
28
-$54.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALT | Director | 21,700 | $2.61 | $56.6K | -$54.2K | 16 | 2026-05-01 |
| Altimmune, Inc. (PIP) Delisted | President and CEO | 822,244 | — | — | $0 | 12 | 2016-11-23 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-01 | ALT | Grant (A) | — | $0 | EDGAR |
| 2026-04-06 | ALT | Buy (P) | +9,200 | $31.3K | EDGAR |
| 2025-12-23 | ALT | Buy (P) | +12,500 | $51.2K | EDGAR |
| 2025-09-29 | ALT | Mixed | −2,714 | $0 | EDGAR |
| 2024-09-30 | ALT | Grant (A) | — | $0 | EDGAR |
| 2023-09-29 | ALT | Grant (A) | — | $0 | EDGAR |
| 2023-07-06 | ALT | Sell (S) | −2,714 | -$40.7K | EDGAR |
| 2022-09-30 | ALT | Grant (A) | — | $0 | EDGAR |
| 2021-09-24 | ALT | Grant (A) | — | $0 | EDGAR |
| 2020-12-02 | ALT | Sell (S) | −8,425 | -$100.4K | EDGAR |